CertificationB2B GuideCE MarkingMDREuropean Market

Electric Wheelchair CE Certification 2026: MDR Transition and What B2B Importers Must Know

Electric Wheelchair CE Certification 2026: MDR Transition and What B2B Importers Must Know

The MDR Landscape for Electric Wheelchairs in 2026


The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Device Directive (MDD 93/42/EEC) after a transition period that ended in stages. For electric wheelchairs classified as medical devices under MDR, the regulation changes have significant implications for manufacturers, importers, and distributors serving the European market.


This guide explains the current MDR requirements specifically for electric wheelchairs and what B2B importers need to verify before placing products on the EU market.


Electric Wheelchair Classification Under MDR


Under MDR, electric wheelchairs are typically classified as:


ClassTypeExamples
Class ILow risk, non-invasiveManual wheelchairs, accessories
Class IIaMedium risk, poweredMost electric wheelchairs with powered mobility functions
Class IIbHigher riskWheelchairs with life-supporting functions or drug delivery

Most standard electric wheelchairs fall under Class IIa. This classification requires notified body involvement, technical documentation review, quality management system (ISO 13485) certification, clinical evaluation report (CER), and post-market surveillance system.


Key MDR Changes


Notified Body Scarcity

Under MDR, notified bodies face stricter designation requirements, reducing available certifiers. Certification timelines have increased from 6-9 months to 12-18 months.


Technical Documentation

MDR Annex II and III specify more detailed requirements covering device description, manufacturing process validation, general safety and performance requirements (GSPR), benefit-risk analysis, and clinical evaluation.


For electric wheelchairs, specific requirements include:

- IEC 60601-1 electrical safety

- IEC 60601-1-2 electromagnetic compatibility

- IEC 62366 usability testing

- ISO 10993 biological evaluation for seat materials

- UN38.3 and IEC 62133 battery safety

- Stability testing including tip resistance on slopes


Clinical Evaluation

MDR raises the bar for clinical evidence including a formal Clinical Evaluation Report (CER), equivalent device justification, Post-Market Clinical Follow-up (PMCF) plan, and demonstrated safety and performance.


UDI Requirements

Unique Device Identification (UDI) codes must be assigned to each device model and registered in EUDAMED.


Authorized Representative

Non-EU manufacturers must appoint an EU Authorized Representative registered with competent authorities.


Practical Checklist for B2B Importers


1. Manufacturer holds valid ISO 13485 certification

2. CE certificate issued under MDR by a designated notified body

3. Notified Body number verifiable on NANDO database

4. Technical documentation complete and available

5. Clinical evaluation report covers the specific device

6. Declaration of Conformity properly signed

7. EU Authorized Representative appointed

8. UDI compliance plan in place

9. Post-market surveillance system operational

10. Product liability insurance covers EU distribution


How MiniElephant Complies


RequirementMiniElephant Status
ISO 13485Certified
CE CertificateIssued under MDR
Notified BodyValid and designated
Technical DocumentationComplete, available for audit
CERUpdated for MiniRedone series
EU Authorized RepresentativeAppointed
Electrical SafetyIEC 60601 compliant
Battery SafetyUN38.3, IEC 62133 compliant

**Contact our compliance team:** [www.semwheelchair.com/contact](https://www.semwheelchair.com/contact)

**Browse CE-certified MiniRedone models:** [www.semwheelchair.com/products](https://www.semwheelchair.com/products)


Interested in MiniElephant Electric Wheelchairs?

Get a customized quotation and product recommendation from our export team. Response within 24 hours.